Adding a test for high‐risk human papillomavirus (hrHPV) to cytological screening enhances
the detection of high‐grade cervical intraepithelial neoplasia (≥ CIN2), but data are …

We prospectively evaluated the 5-year predictive values of adding high-risk human
papillomavirus (hrHPV) testing to cytology for the detection of⩾ cervical intraepithelial …

Objective To establish the prevalence of high‐grade cervical intraepithelial neoplasia
(CIN2+) in women referred to colposcopy with persistent high‐risk human papillomavirus …

Background: Cervical cancer risks, estimated by using cervical intraepithelial neoplasia
grade 3 (CIN3) or more severe diagnoses (≥ CIN3) endpoints, have not been quantified for …

Importance Cervical cancer can be prevented with detection and treatment of precancerous
cell changes caused primarily by high-risk types of human papillomavirus (hrHPV), the …

High‐risk human papillomavirus (hrHPV) testing has a higher sensitivity but lower specificity
than cytology for detection of high‐grade intraepithelial neoplasia (CIN). To avoid over …

Introduction Human papillomavirus (HPV) testing as the primary cervical cancer screening
method is implemented in several countries. We report data from the first round of a large …

Introduction In randomized studies, testing for high‐risk (HR) human papillomavirus (hrHPV)
has been more sensitive than conventional cytology in detecting cervical intraepithelial …

The validity of testing for high‐risk types of human papillomavirus (HPV) in cervical cancer
prevention programs is undetermined. We compared the performance on primary screening …

Cytological cervical screening is rather inefficient because of relatively high proportions of
false negative and false positive smears. To evaluate the efficiency of high‐risk human …